It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Exhaustion of cytotoxic effector natural killer (NK) and CD8+ T cells have important functions in the establishment of persistent viral infections, but how exhaustion is induced during chronic hepatitis C virus (HCV) infection remains poorly defined. Here we show, using the humanized C/OTg mice permissive for persistent HCV infection, that NK and CD8+ T cells become sequentially exhausted shortly after their transient hepatic infiltration and activation in acute HCV infection. HCV infection upregulates Qa-1 expression in hepatocytes, which ligates NKG2A to induce NK cell exhaustion. Antibodies targeting NKG2A or Qa-1 prevents NK exhaustion and promotes NK-dependent HCV clearance. Moreover, reactivated NK cells provide sufficient IFN-γ that helps rejuvenate polyclonal HCV CD8+ T cell response and clearance of HCV. Our data thus show that NKG2A serves as a critical checkpoint for HCV-induced NK exhaustion, and that NKG2A blockade sequentially boosts interdependent NK and CD8+ T cell functions to prevent persistent HCV infection.
Immune cells may become less responsive, or ‘exhausted’, upon chronic viral infection, but the underlying mechanism and crosstalk are still unclear. Here the authors show that, upon chronic hepatitis C virus (HCV) infection, natural killer cell exhaustion is induced by NKG2A signalling to instruct downstream exhaustion of CD8+ T cells and HCV persistence.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Chinese Academy of Sciences, The Joint Laboratory of Infection and Immunity at Institut Pasteur of Shanghai and Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, The Key Laboratory of Infection and Immunity, Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309)
2 The First Hospital of Jilin University, Department of Hepatology, Changchun, China (GRID:grid.430605.4)
3 Chinese Academy of Sciences, The Joint Laboratory of Infection and Immunity at Institut Pasteur of Shanghai and Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, The Key Laboratory of Infection and Immunity, Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); University of Chinese Academy of Sciences, College of Life Sciences, Beijing, China (GRID:grid.410726.6) (ISNI:0000 0004 1797 8419)
4 Chinese Academy of Sciences, The Joint Laboratory of Infection and Immunity at Institut Pasteur of Shanghai and Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, The Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309)
5 Chinese Academy of Sciences, The Joint Laboratory of Infection and Immunity at Institut Pasteur of Shanghai and Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, The Key Laboratory of Infection and Immunity, Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); ShanghaiTech University, School of Life Science and Technology, Shanghai, China (GRID:grid.440637.2)
6 The Third Military Medical University, Institute of Immunology, Chongqing, China (GRID:grid.410570.7) (ISNI:0000 0004 1760 6682)
7 Chinese Academy of Sciences, The State Key Laboratory of Virology and Center for Viral Pathology, Wuhan Institute of Virology, Wuhan, China (GRID:grid.9227.e) (ISNI:0000000119573309)
8 Chinese Academy of Sciences, The Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309)
9 Chinese Academy of Sciences, The Key Laboratory of Infection and Immunity, Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309)
10 Chinese Academy of Sciences, The Joint Laboratory of Infection and Immunity at Institut Pasteur of Shanghai and Institute of Biophysics, Beijing, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, The Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, The State Key Laboratory of Virology and Center for Viral Pathology, Wuhan Institute of Virology, Wuhan, China (GRID:grid.9227.e) (ISNI:0000000119573309)